Absorption |
Blood-Brain Barrier | BBB- | 0.7103 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.5238 |
P-glycoprotein Substrate | Substrate | 0.6705 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9000 |
Non-inhibitor | 0.8947 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6915 |
Distribution |
Subcellular localization | Mitochondria | 0.7449 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6796 |
CYP450 2D6 Substrate | Substrate | 0.5400 |
CYP450 3A4 Substrate | Non-substrate | 0.5685 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7008 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9007 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7656 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6438 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6713 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8321 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5832 |
Non-inhibitor | 0.5915 |
AMES Toxicity | Non AMES toxic | 0.7519 |
Carcinogens | Non-carcinogens | 0.8972 |
Fish Toxicity | High FHMT | 0.9782 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9896 |
Honey Bee Toxicity | Low HBT | 0.6496 |
Biodegradation | Not ready biodegradable | 0.9640 |
Acute Oral Toxicity | III | 0.6131 |
Carcinogenicity (Three-class) | Non-required | 0.7185 |